BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26335332)

  • 1. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).
    Kypta A; Blessberger H; Hoenig S; Saleh K; Lambert T; Kammler J; Fellner F; Lichtenauer M; Steinwender C
    J Magn Reson Imaging; 2016 Mar; 43(3):574-84. PubMed ID: 26335332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Awad K; Griffin J; Crawford TC; Lane Cox S; Ferrick K; Mazur A; Pena RE; Lloyd SG; Michalski J; Johnson W; Bailey WM
    Heart Rhythm; 2015 Oct; 12(10):2155-61. PubMed ID: 26049048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study.
    Zbinden R; Wollmann C; Brachmann J; Michaelsen J; Steinwender C; Kovoor P; Kelle S; McGavigan AD; Ching CK; Figtree GA; Schmidt J; Timmel T; Lotz J
    Europace; 2019 Nov; 21(11):1678-1685. PubMed ID: 31322701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Mazur A; McCotter C; Woodard PK; Rosenthal L; Johnson W; Mela T;
    Heart Rhythm; 2016 Feb; 13(2):464-71. PubMed ID: 26409098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Rosenthal L; Fananapazir L; Gleva M; Mazur A; Rinaldi CA; Kypta A; Merkely B; Woodard PK;
    Heart Rhythm; 2015 Jun; 12(6):1183-91. PubMed ID: 25680307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads.
    Sheldon SH; Bunch TJ; Cogert GA; Acker NG; Dalzell CM; Higgins JV; Espinosa RE; Asirvatham SJ; Cha YM; Felmlee JP; Watson RE; Anderson JL; Brooks MH; Osborn JS; Friedman PA
    Heart Rhythm; 2015 Feb; 12(2):345-9. PubMed ID: 25433144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study.
    Gold MR; Sommer T; Schwitter J; Al Fagih A; Albert T; Merkely B; Peterson M; Ciuffo A; Lee S; Landborg L; Cerkvenik J; Kanal E;
    J Am Coll Cardiol; 2015 Jun; 65(24):2581-2588. PubMed ID: 25982014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator.
    Russo RJ; Costa HS; Silva PD; Anderson JL; Arshad A; Biederman RW; Boyle NG; Frabizzio JV; Birgersdotter-Green U; Higgins SL; Lampert R; Machado CE; Martin ET; Rivard AL; Rubenstein JC; Schaerf RH; Schwartz JD; Shah DJ; Tomassoni GF; Tominaga GT; Tonkin AE; Uretsky S; Wolff SD
    N Engl J Med; 2017 Feb; 376(8):755-764. PubMed ID: 28225684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators.
    Naehle CP; Strach K; Thomas D; Meyer C; Linhart M; Bitaraf S; Litt H; Schwab JO; Schild H; Sommer T
    J Am Coll Cardiol; 2009 Aug; 54(6):549-55. PubMed ID: 19643318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs).
    Gimbel JR; Kanal E; Schwartz KM; Wilkoff BL
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):270-3. PubMed ID: 15826257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices.
    Nazarian S; Hansford R; Rahsepar AA; Weltin V; McVeigh D; Gucuk Ipek E; Kwan A; Berger RD; Calkins H; Lardo AC; Kraut MA; Kamel IR; Zimmerman SL; Halperin HR
    N Engl J Med; 2017 Dec; 377(26):2555-2564. PubMed ID: 29281579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of magnetic resonance imaging scanning in patients with cardiac resynchronization therapy-defibrillators incorporating quadripolar left ventricular leads.
    Rinaldi CA; Vitoff PJ; Nair DG; Bernstein R; Mountantonakis SE; Rapacciuolo A; Carter N; Tse HF; Green UB
    Heart Rhythm; 2020 Dec; 17(12):2064-2071. PubMed ID: 32911050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads.
    Higgins JV; Gard JJ; Sheldon SH; Espinosa RE; Wood CP; Felmlee JP; Cha YM; Asirvatham SJ; Dalzell C; Acker N; Watson RE; Friedman PA
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1284-90. PubMed ID: 24809591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI Safety for Patients Implanted With the MRI Ready ICD System: MRI Ready Study Results.
    Nazarian S; Cantillon DJ; Woodard PK; Mela T; Cline AM; Strickberger AS;
    JACC Clin Electrophysiol; 2019 Aug; 5(8):935-943. PubMed ID: 31439295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead.
    Wollmann CG; Steiner E; Vock P; Ndikung B; Mayr H
    J Cardiovasc Magn Reson; 2012 Sep; 14(1):67. PubMed ID: 23009683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE study.
    Wollmann CG; Thudt K; Kaiser B; Salomonowitz E; Mayr H; Globits S
    J Cardiovasc Magn Reson; 2014 May; 16(1):30. PubMed ID: 24886167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla.
    Bauer WR; Lau DH; Wollmann C; McGavigan A; Mansourati J; Reiter T; Frömer S; Ladd ME; Quick HH
    Sci Rep; 2019 Dec; 9(1):18243. PubMed ID: 31796767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical safety and performance of a MRI conditional pacing system in patients undergoing cardiac MRI.
    Ching CK; Chakraborty RN; Kler TS; Pumprueg S; Ngarmukos T; Chan JYS; Anand S; Yadav R; Sitthisook S; Yim KW; Jaswal RK; Bhargava K
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1389-1395. PubMed ID: 29090491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocenter Investigation Micra® MRI study (MIMICRY): feasibility study of the magnetic resonance imaging compatibility of a leadless pacemaker system.
    Blessberger H; Kiblboeck D; Reiter C; Lambert T; Kellermair J; Schmit P; Fellner F; Lichtenauer M; Kypta A; Steinwender C; Kammler J
    Europace; 2019 Jan; 21(1):137-141. PubMed ID: 29986008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.